A Phase 1 Single/Multiple Dose Study Of PF-06293620 To Assess Safety, Tolerability And Pharmacokinetics In Subjects With Type 2 Diabetes Mellitus
Clinical trial NCT02211261 · COMPLETED
Trial details
- NCT number
- NCT02211261
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-15
- Primary completion
- 2017-01-27
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.